TenderDekho Logo
GEM

Municipal Corporation Of Delhi Absorbable Hemostat (V2) Tender NEW DELHI 2025 – MDR 2017 Compliance, Medical Device Licenses & Batch Test Reports

Bid Publish Date

21-Oct-2025, 3:22 pm

Bid End Date

31-Oct-2025, 4:00 pm

Progress

RA
Issue21-Oct-2025, 3:22 pm
Reverse AuctionCompleted
AwardCompleted
Explore all 4 tabs to view complete tender details

Quantity

250

Bid Type

Two Packet Bid

Categories 1

Tender Overview

The Municipal Corporation Of Delhi (MCD), based in NEW DELHI, DELHI, invites bids for Absorbable Hemostat (V2). The tender seeks a medically certified hemostatic product with CDSCO approval, batch test reports, and OEM after-sales support. Key quantities and total contract value are not disclosed in the data provided. Bidders must comply with the option clause allowing up to 25% quantity variation and adhere to safety mandates for work in high-risk environments. Special emphasis is placed on regulatory compliance, including MDR 2017 amendments and proper licensing. The tender foregrounds supplier qualification through complete certifications and advanced sample approval, ensuring product equivalence to the buyer’s framework prior to bulk supply. The procurement focuses on medical-grade hemostats suitable for emergency and operative use, with explicit requirements around shelf life and packaging. A strong differentiator is the requirement for a registered Indian office for OEM support if the product is imported, ensuring after-sales service within India. This tender emphasizes compliance, traceability, and risk management in public-health procurement.

Technical Specifications & Requirements

  • Product: Absorbable Hemostat (V2)
  • Regulatory Compliance: MDR 2017 amended till date; CDSCO approval required; valid Medical Device license under Drugs and Cosmetics Act 1940; Manufacturer Facility Certification
  • Documentation & Testing: Batchwise test reports as per MDR 2017; submission of all certifications/licenses/test reports with bid or at supply; advance sample submission and buyer approval workflow
  • Product Attributes: Composition of material (100% enumerated material); fully absorbable; complete absorption period; time to hemostasis; dimensions with Width ±0.5 inch and Length ±0.5 inch; powder quantity specifics
  • Shelf Life: Minimum shelf life at delivery; months from manufacture
  • Packaging: Type of packing specified; advance sample requirement post-award
  • OEM/Import: If imported, OEM registered office in India for after-sales service; submission of certificate
  • Delivery & Sampling: Advance sample within days of award; potential delivery timeline adjustments for sample approval; LD rules apply for deviations

Terms, Conditions & Eligibility

  • Option Clause: Quantity may increase/decrease by up to 25%; extended delivery time calculated by formula; minimum 30 days
  • Work Environment: Compliance with workmen compensation, insurance, public liability, and safety for Extra High Voltage environments
  • Sample & Supply: Advance sample approval required; 5 samples for buyer; supply must conform to approved sample; bulk supply after approval
  • Documentation: Submission of GST, PAN, experience certificates, financial statements, EMD documentation, OEM authorizations, and technical compliance certificates as applicable
  • Delivery & Payment: Delivery terms tied to contract and option clause; payment terms specified in supply contract; penalties/LD to be defined
  • Warranty/After-Sales: Manufacturer facility certification and ongoing post-delivery support as per buyer requirements

Key Specifications

  • Product: Absorbable Hemostat (V2)

  • Composition: 100% enumerated material

  • Regulatory: MDR 2017 compliance; CDSCO approval

  • Licenses: Medical Device license under Drugs and Cosmetics Act 1940

  • Batch Testing: Test report per MDR 2017 for each batch

  • Dimensions: Width ±0.5 inch; Length ±0.5 inch

  • Shelf Life: Minimum shelf life from manufacture date

  • Advance Sample: 5 samples required for buyer approval within 5 days of award

  • Packing: Type of packing as specified by buyer

Terms & Conditions

  • Option Clause enables ±25% quantity variation and pro-rated delivery time

  • Imported products require Indian OEM presence for after-sales service

  • Advance sample approval process precedes bulk manufacturing and supply

Important Clauses

Payment Terms

Payment terms to be defined in contract; compliance with delivery milestones and LD applicable per schedule

Delivery Schedule

Delivery periods commence from last date of original/extended delivery order; option-based extensions with minimum 30 days

Penalties/Liquidated Damages

LD provisions may apply for non-compliance or delays; details to be provided in contract

Bidder Eligibility

  • Experience in supplying medical devices compliant with MDR 2017

  • Registered Indian OEM or authorized seller for imported products

  • Valid CDSCO licenses and batch testing capabilities

Documents 3

GeM-Bidding-8496672.pdf

Main Document

CATALOG-Specification-1

CATALOG Specification

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Absorbable Hemostat (V2),Absorbable Hemostat (V2)

N/a

BHOPAL, MADHYA PRADESH

Posted: 20 June 2025
Closed: 11 July 2025
GEM

Absorbable Hemostat (V2)

All India Institute Of Medical Sciences (aiims)

SOUTH DELHI, DELHI

Posted: 14 May 2025
Closed: 4 June 2025
GEM

Absorbable Hemostat (V2)

Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)

THIRUVANANTHAPURAM, KERALA

Posted: 24 November 2025
Closed: 4 December 2025
GEM

Absorbable Hemostat (V2)

Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)

Posted: 19 November 2024
Closed: 29 November 2024
GEM

Sree Chitra Tirunal Institute SCTIMST Absorbable Hemostat Tender V2 Kerala 2025

Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)

THIRUVANANTHAPURAM, KERALA

Posted: 1 December 2025
Closed: 11 December 2025
GEM

Technical Specifications 1 Item

Item #1 Details

View Catalog
Category Specification Requirement
GENERAL Product Description Absorbable Hemostat
PRODUCT INFORMATION Composition of Material (made of 100% of the enumerated material) Oxidized Regenerated Cellulose (ORC)
PRODUCT INFORMATION Fully Absorb-able as approved by CDSCO Yes
PRODUCT INFORMATION Complete Absorption period 7 to 14 Days
PRODUCT INFORMATION Time to achieve complete hemostatis 1 to 5 minutes
PRODUCT INFORMATION Width (±0.5 inch) 2 inch
PRODUCT INFORMATION Length (±0.5 inch) 3 inch
PRODUCT INFORMATION Quantity for Powdered Hemostat NA
PACKAGING Type of Packing Moisture Proof Packing
CERTIFICATIONS Compliance to Medical Device Rule (MDR) 2017 as amended till date Yes
CERTIFICATIONS Availability of valid medical device license for the product issued from the competent authority defined under Drugs and Cosmetic Act 1940 and Rules made there under as amended till date Yes
CERTIFICATIONS Manufacturer Facility Certification ISO:13485 (Latest)
CERTIFICATIONS Availability of Test Report for each supplied batch/product as per Medical Device Rule (MDR) 2017 as amended till date Yes
CERTIFICATIONS Submission of all necessary certifications, licenses and test reports to the buyer at the time of bid submission or along with supplies as per buyer requirement Yes
SHELF LIFE Shelf life in months from the date of manufacture 36, 48, 60 Or higher
SHELF LIFE Minimum shelf life of the product at the time of delivery to the consignee 3/4 th of Total Shelf Life
ADVANCE SAMPLE Agree to provide advance sample of the product for buyer's approval after award of contract and before commencement of supply in case of bidding Yes

Required Documents

1

GST registration certificate

2

PAN card

3

Experience certificates showing prior similar medical device supply

4

Financial statements (last 3 years) and bank statements

5

EMD/Security deposit submission details

6

Technical bid documents and compliance certificates

7

OEM authorization letter (for non-native manufacturers)

8

CDSCO/MDR related licenses and batch test reports

9

Manufacturer Facility Certification

10

Product-specific test reports for each batch

Reverse Auction Schedule

Completed

Start

06-Dec-2025, 10:00 am

End

08-Dec-2025, 10:00 am

Duration: 48 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Reverse Auction Results Final Prices

These are the final prices after the reverse auction event. Prices may be lower than initial bids.

Rank Seller Final Price Item
L1AEGIS LIFESCIENCES PRIVATE LIMITED   Under PMA Winner ₹87,925Item Categories : Absorbable Hemostat (V2)
L2DIKSHA MEDICOS   Under PMA₹88,025Item Categories : Absorbable Hemostat (V2)
L3PANKAJ PHARMA   Under PMA₹3,15,000Item Categories : Absorbable Hemostat (V2)

🎉 L1 Winner

AEGIS LIFESCIENCES PRIVATE LIMITED   Under PMA

Final Price: ₹87,925

Frequently Asked Questions

Key insights about DELHI tender market

How to bid for the absorbable hemostat tender in New Delhi 2025?

Bidders must submit GST, PAN, experience certificates, financial statements, EMD, OEM authorizations, and CDSCO MDR 2017 licenses. Include batch test reports for each lot and advance sample approval within 5 days of contract award. Ensure Indian OEM presence for imported products and comply with the 25% option clause.

What documents are required for MDR 2017 compliant hemostat tender Delhi?

Submit CDSCO MDR 2017 compliance certificates, Medical Device license under the Drugs and Cosmetics Act, Manufacturer Facility Certification, and batch test reports. Include GST, PAN, experience certificates, financial statements, and OEM authorization if applicable.

What are the packaging and dimensions for absorbable hemostat V2?

Product must meet Width ±0.5 inch and Length ±0.5 inch. Packaging type should be specified in the contract. Ensure packaging meets shelf-life and handling requirements for medical devices.

What is the supplier’s obligation for advance samples and approvals?

Submit 5 advance samples within 5 days of award. The buyer will approve or specify modifications within 5 days. If delayed by the buyer, the delivery schedule will be adjusted without LD; bulk supply must conform to approved sample.

What is the option clause for quantity variation in the Delhi tender?

The purchaser may increase/decrease the quantity up to 25% of bid quantity. Extended delivery time is calculated as ( Increased quantity ÷ Original quantity ) × Original delivery period, with a minimum of 30 days.

Which regulatory standards must the absorbable hemostat meet for Delhi procurement?

Products must be MDR 2017 compliant, CDSCO approved, with valid medical device licenses under the Drugs and Cosmetics Act, and batch test reports for each supply lot.

Are imported products eligible and what support is required?

Imported products are eligible only if the OEM has a registered Indian office for after-sales service. Provide an OEM authorization and local service support details as part of bid submission.

What happens if there is a delay in sample approval affecting delivery?

Delivery period is reset to account for the buyer’s delay in sample approval. No liquidated damages apply for the portion of supply affected by the approved delay, with modifications communicated before bulk supply.